New Roche Chairman Promises To Follow Predecessor's Tight-Fisted Ways, Eyes Acquisitions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Roche Holding AG’s (ROG) new chairman signaled today he’ll follow his predecessor’s tight-fisted approach toward acquisitions even now that the drugmaker has paid down much of the debt from its last big deal.

Roche has been willing in the past to abandon planned purchases over price, and the company will review opportunities very carefully, said Christoph Franz, who was elected chairman today at the drugmaker’s annual meeting in Basel, Switzerland.

Help employers find you! Check out all the jobs and post your resume.

Back to news